CreditReports.dk
HomeScreen companies

ASCENDIS PHARMA A/S Financials, key figures and credit report

CVR number: 29918791 Established 2006 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Tuborg Boulevard 12, 2900 Hellerup tel: 36944486
Net sales 720.1 mEUR FY 2025 +98% vs 2024
EBIT margin -18.9 % FY 2025 +57.7 pp vs 2024
Net debt - 173.6 mEUR FY 2025 -7.8% vs 2024
Quick ratio 0.8 FY 2025 -0.1 vs 2024

Income statement (mEUR)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales7.7851.17266.72363.64720.13
Costs of manufacturing-3.52-12.14-44.40-44.26-94.92
Gross profit4.2539.04222.32319.38625.22
Costs of marketing- 160.18- 221.23- 264.41- 291.14- 457.87
Other operating expenses- 295.87- 379.62- 413.45- 307.00- 303.62
EBIT- 451.79- 561.81- 455.54- 278.76- 136.27
Other financial income59.7252.1843.8625.61114.00
Other financial expenses-3.91-50.49-44.06- 100.03- 206.69
Net income from associates (fin.)12.04-17.70-18.39-20.0616.31
Pre-tax profit- 383.94- 577.82- 474.14- 373.24- 212.65
Income taxes0.37-5.38-7.30-4.84-15.38
Net earnings- 383.58- 583.19- 481.45- 378.08- 228.03

Assets (mEUR)

2021
2022
2023
2024
2025
Intangible rights5.274.834.424.033.71
Intangible assets total5.274.834.424.033.71
Other tangible assets126.05129.09110.6398.71146.48
Tangible assets total126.05129.09110.6398.71146.48
Participating interests38.3422.935.6913.5732.53
Other non-current investments107.567.49
Investments total145.9130.425.6913.5732.53
Non-current other receivables1.811.922.132.3210.87
Long term receivables total1.811.922.132.3210.87
Inventories total75.41130.67208.93295.61301.53
Current trade debtors2.2011.9135.87166.28141.33
Prepayments and accrued income25.2331.7238.5828.2733.72
Current other receivables255.89303.5226.379.3814.58
Current deferred tax assets0.890.880.801.771.78
Short term receivables total284.21348.03101.63205.71191.41
Cash and bank deposits446.27444.77392.16559.54616.04
Cash and cash equivalents446.27444.77392.16559.54616.04
Balance sheet total (assets)1 084.921 089.74825.591 179.491 302.57

Equity and liabilities (mEUR)

2021
2022
2023
2024
2025
Share capital7.657.677.758.158.32
Other reserves875.99255.67- 153.45- 113.86- 171.14
Retained earnings383.58583.19481.45378.08228.03
Profit of the financial year- 383.58- 583.19- 481.45- 378.08- 228.03
Shareholders equity total883.63263.35- 145.70- 105.71- 162.82
Non-current loans from credit institutions97.97387.56223.00365.08385.25
Non-current leasing loans95.40
Non-current other liabilities2.96172.165.955.001.12
Non-current deferred tax liabilities5.837.269.62
Non-current liabilities total100.93655.12234.78377.34396.00
Current loans from credit institutions7.0011.6314.1733.3357.14
Current leasing loans13.79
Short-term deferred tax liabilities0.205.492.301.226.43
Other non-interest bearing current liabilities89.37133.02686.13773.23834.48
Current provisions1.197.3432.7299.15166.40
Accruals and deferred income2.601.180.944.94
Current liabilities total100.36171.27736.51907.861 069.39
Balance sheet total (liabilities)1 084.921 089.74825.591 179.491 302.57
Page generated